Select for export Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2021.2020382 PubMed 34979875 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2022-01-02 Altman BR, Earleywine M, De Leo J. Europe PMC Published psilocybin DepressionHealthcare WorkersAdverse Events Other More
Select for export Psychedelic Agents as Potential Therapeutics for Obsessive Compulsive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX DOAJ (DOAJ: Directory of Open Access Journals) 2021-12-31 Josh Nagra OpenAlex Published psilocybin AnxietyOCDReceptor Pharmacology Other More
Select for export Should Adolescents be Included in Emerging Psychedelic Research? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7202/1089784ar Copy citation Copy BibTeX Canadian Journal of Bioethics 2021-12-31 Khaleel Rajwani OpenAlex Published psilocybin AdolescentsSafety Other More
Select for export Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_267 PubMed 34734390 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P PubMed Published psilocybin AnxietyNeuroplasticityMechanism of Action Review Article More
Select for export Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_282 PubMed 34811715 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Agin-Liebes G, Davis AK. Europe PMC Published psilocybin DepressionBrain ImagingAging Clinical Trial More
Select for export Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1568026621666211201145800 PubMed 34852736 Copy citation Copy BibTeX Current Topics in Medicinal Chemistry 2021-12-31 Sousa TR, Rema J, Machado S, Novais F. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_284 PubMed 34910289 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Rieser NM, Herdener M, Preller KH PubMed Published psilocybin AddictionNeuroplasticityMechanism of Action Other More
Select for export The Potential of Psychedelics for End of Life and Palliative Care. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_278 PubMed 34958455 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR PubMed Published psilocybin DepressionEnd-of-Life DistressWellbeing Review Article More
Select for export LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-12-21 University Hospital, Basel, Switzerland ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12904-021-00889-x PubMed 34930220 Copy citation Copy BibTeX BMC palliative care 2021-12-19 Niles H, Fogg C, Kelmendi B, Lazenby M PubMed Published psilocybin End-of-Life DistressSpiritualityClinical Trial Clinical Trial More
Select for export Beating pain with psychedelics: Matter over mind? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neubiorev.2021.12.005 PubMed 34922987 Copy citation Copy BibTeX Unknown journal 2021-12-15 Elman I, Pustilnik A, Borsook D. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2021.11.29 Copy citation Copy BibTeX Psychiatric News 2021-11-29 Linda M. Richmond OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2021.12.14 Copy citation Copy BibTeX Psychiatric News 2021-11-28 David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman OpenAlex Published psilocybin DepressionAnxietyConsciousness Clinical Trial More
Select for export Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06027-y PubMed 34812901 Copy citation Copy BibTeX Unknown journal 2021-11-22 Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Systematic Review More
Select for export Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.2487 PubMed 34743319 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2021-11-21 Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE Europe PMC Published psilocybinpsilocin DepressionAnxietyPharmacology Clinical Trial More
Select for export Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1126/sciadv.abh2399 PubMed 34788104 Copy citation Copy BibTeX Science Advances 2021-11-16 Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J Europe PMC Published psilocybin Mechanism of ActionBiomarkers Other More
Select for export Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-021-01706-y PubMed 34750350 Copy citation Copy BibTeX Translational Psychiatry 2021-11-07 Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-10-14 Maryland Oncology Hematology, PA ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyClinical Trial Clinical Trial More
Select for export Delix to synthesize psychedelic drugs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cen-09936-buscon3 Copy citation Copy BibTeX C&EN Global Enterprise 2021-10-03 Ryan Cross OpenAlex Published psilocybin DepressionClinical Trial Clinical Trial More
Select for export Novel antidepressant drugs: Beyond monoamine targets. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852921000791 PubMed 34588093 Copy citation Copy BibTeX Unknown journal 2021-09-29 Gonda X, Dome P, Neill JC, Tarazi FI. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
